New ingredient approvals

FDA photo

Cancer institute head named acting FDA chief

By Hank Schultz

Dr Ned Sharpless, MD, who is the current head of the National Cancer Institute, will be the interim head of the Food and Drug Administration when Dr Scott Gottlieb, MD, leaves next month.

Getty Images

MacKay leaves CRN for cannabis firm; Shao returns in interim role

By Hank Schultz

Andrew Shao, PhD, will replace Duffy MacKay, ND, as head of scientific and regulatory affairs at the Council for Responsible Nutrition in an interim role. MacKay is leaving the organization for a similar role at cannabis specialist CV Sciences.

Getty Images

From the editor's desk

What should DSHEA 2.0 look like? Here are a couple of suggestions

By Hank Schultz

On Monday FDA Commissioner Scott Gottlieb put forward some ideas about where the regulation of dietary supplements should go in the coming years. This is an opportunity that should not be missed. What should be tops on the industry’s wish list?

Getty Images

The big issues for 2019: CBD, the microbiome and more

By Stephen Daniells, Hank Schultz and Adi Menayang

The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five of our Top 10 big issues that will impact the dietary supplements industry in 2019.

Follow us

Featured Events

View more

Products

View more

Webinars